NCT00119171View on ClinicalTrials.gov

Ispinesib In Combination With Capecitabine In Patients With Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

November 30, 2004

Conditions
Solid Tumor Cancer
Interventions
DRUG

Ispinesib

DRUG

Capecitabine

Trial Locations (1)

78229

GSK Investigational Site, San Antonio

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY